Genetic and Epigenetic Changes in Pancreatic Cancer
Author Information
Author(s): Delpu Yannick, Hanoun Naïma, Lulka Hubert, Sicard Flavie, Selves Janick, Buscail Louis, Torrisani Jérôme, Cordelier Pierre
Primary Institution: Inserm UMR 1037- University of Toulouse III, Cancer Research Center of Toulouse (CRCT)
Hypothesis
The review aims to assemble current information on genetic mutations and epigenetic disorders that affect genes during pancreatic carcinogenesis.
Conclusion
Understanding the molecular alterations in pancreatic carcinogenesis could lead to new clinical tools for early diagnosis and effective therapies.
Supporting Evidence
- Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers worldwide.
- Up to 60% of patients have advanced PDAC at the time of diagnosis.
- Genetic alterations such as K-RAS mutations are frequently observed in PDAC samples.
- Alterations in DNA methylation patterns lead to deregulation of gene expression.
- Understanding these molecular alterations could provide new clinical tools for early diagnosis.
Takeaway
Pancreatic cancer starts from small changes in genes and DNA that can lead to serious problems, and finding these changes early can help doctors treat the cancer better.
Methodology
The review discusses various genetic and epigenetic alterations involved in pancreatic cancer development based on existing literature.
Limitations
The study primarily focuses on known genetic and epigenetic changes without extensive new experimental data.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website